Clinical trials
Recruiting Phase 2/3 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Research UK | 3 |
| Daiichi Sankyo | 1 |
| GE Healthcare | 1 |
| Gynaecologisch Oncologisch Centrum Zuid | 1 |
| N.N. Alexandrov National Cancer Centre | 1 |
| RenJi Hospital | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 9 |
| Colorectal Neoplasms | 4 |
| Hematologic Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Erdheim-Chester Disease | 2 |
| Fallopian Tube Neoplasms | 2 |
| Glioma | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.